Ashburton (Jersey) LTD Eli Lilly & CO Transaction History

Ashburton (Jersey) LTD

$200 Million
Q4 2023

A detailed history of Ashburton (Jersey) LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Ashburton (Jersey) LTD holds 275 shares of LLY stock, worth $241,312. This represents 0.07% of its overall portfolio holdings.

Number of Shares

275

Previous 275 -0.0%

Holding current value

$241,312

Previous $129,000 14.73%

% of portfolio

0.07%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $64,073 - $75,533	-122 Reduced 44.36%	153 $89,000
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $225,175 - $301,085	-642 Reduced 70.01%	275 $128,000
Q1 2023 May 17, 2023	SELL	$310.63 - $364.82 $1.49 Million - $1.75 Million	-4,809 Reduced 83.99%	917 $315,000
Q4 2022 Apr 26, 2023	SELL	$321.55 - $374.67 $413,513 - $481,825	-1,286 Reduced 18.34%	5,726 $2.1 Million
Q3 2022 Apr 26, 2023	BUY	$296.48 - $337.87 $62,557 - $71,290	211 Added 3.1%	7,012 $2.27 Million
Q2 2022 May 26, 2023	SELL	$278.73 - $327.27 $141,594 - $166,253	-508 Reduced 6.55%	7,252 $2.35 Million
Q1 2022 May 26, 2023	SELL	$234.69 - $291.66 $81,672 - $101,497	-348 Reduced 4.29%	7,760 $2.25 Million
Q4 2021 May 26, 2023	BUY	$224.85 - $279.04 $1.62 Million - $2.01 Million	7,191 Added 784.19%	8,108 $2.24 Million
Q3 2021 May 26, 2023	BUY	$221.6 - $272.71 $6,869 - $8,454	31 Added 0.39%	7,895 $1.82 Million
Q2 2021 May 26, 2023	BUY	$180.55 - $233.54 $81,789 - $105,793	453 Added 6.11%	7,864 $1.81 Million
Q1 2021 May 26, 2023	BUY	$164.32 - $212.72 $1.07 Million - $1.38 Million	6,494 Added 708.18%	7,411 $1.39 Million
Q4 2020 May 23, 2023	BUY	$130.46 - $172.63 $990,452 - $1.31 Million	7,592 Added 827.92%	8,509 $1.44 Million
Q2 2020 Aug 06, 2020	SELL	$136.42 - $164.18 $348,962 - $419,972	-2,558 Reduced 27.33%	6,801 $1.12 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $106 - $132	-1 Reduced 0.01%	9,359 $1.23 Million
Q3 2019 Nov 15, 2019	BUY	$106.79 - $116.16 $41,648 - $45,302	390 Added 4.35%	9,360 $1.05 Million
Q2 2019 Jul 26, 2019	SELL	$110.79 - $129.32 $4,431 - $5,172	-40 Reduced 0.44%	8,970 $994,000
Q1 2019 May 20, 2019	SELL	$111.31 - $131.02 $106,301 - $125,124	-955 Reduced 9.58%	9,010 $1.17 Million
Q4 2018 Feb 28, 2019	BUY	$105.9 - $118.64 $188,502 - $211,179	1,780 Added 21.75%	9,965 $1.15 Million
Q4 2018 Feb 04, 2019	SELL	$105.9 - $118.64 $126,021 - $141,181	-1,190 Reduced 12.69%	8,185 $698,000
Q3 2018 Nov 05, 2018	BUY	$85.86 - $107.31 $102,173 - $127,698	1,190 Added 14.54%	9,375 $1.01 Million
Q2 2018 Sep 06, 2018	BUY	$75.7 - $86.88 $49,962 - $57,340	660 Added 8.77%	8,185 $698,000
Q1 2018 May 25, 2018	BUY	$74.21 - $87.6 $558,430 - $659,190	7,525 New	7,525 $582,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashburton (Jersey) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ashburton (Jersey) LTD with notifications on news.

Account

Ashburton (Jersey) LTD Eli Lilly & CO Transaction History